
Medable’s flexible and modular platform means that we can deploy their platform to shift a number of scheduled visits from onsite to remote while still maintaining the patient/investigator relationship that is core to every clinical study.

Dr. Robert Bissonnette, MD, FRCPC, founder and CEO of Innovaderm